Skip to main content
The University of Arizona Wordmark Line Logo White
BIO5 Institute | Home
I am a

Membership

Newsletter

Directory

home home

Main navigation

  • What is the BIO5 Institute? Getting Started Become a Member Membership Directory Visit Invest In BIO5
  • Researchers Postdoctoral Researchers Students Industry Partners Community
  • Aging and the Brain Bioimaging Bioinformatics Infectious Diseases & Microbiome Precision Medicine Technology-Enabled Health Training the Next Generation
  • Improving Health Engaging Students Impacting Arizona
  • Labs & Facilities Research Services & Tools Data & Software Services Funding Professional Development & Training
  • News Science Talks Podcast Newsletter Calendar of Events Annual Events Media & Brand Assets Media Contact
  1. Home
  2. Cancer

Cancer

Cancer

Image
A scientist in a lab coat and gloves examines a petri dish closely.

AZBio Awards to honor two U of A faculty members, startup company

Sept. 10, 2025

BIO5 member Melissa Herbst-Kralovetz will be honored as Biosciences Researcher of the Year at the 2025 AZBio Awards for her work on women’s health and gynecologic diagnostics. BIO5 member Eric M. Reiman will receive the Pioneer Award for Lifetime Achievement, and the U of A startup LifeSpan Digital Health will be recognized.

Read more in U of A Research and Partnerships
Image
A person standing outdoors, smiling, with blooming trees and a mountainous backdrop. The individual is wearing a patterned blue shirt and gray pants.

Pediatric oncologist Emmanuel Katsanis: Transforming cancer care for Arizona’s youth

Sept. 3, 2025

BIO5 member Emmanuel Katsanis of the University of Arizona Comprehensive Cancer Center has transformed pediatric cancer care in Arizona, leading advances in bone marrow transplantation and immunotherapy that have raised survival rates and expanded access to lifesaving treatments.

Read more in U of A Cancer Center
Image
Two vials of chemotherapy drugs, one clear and one amber-colored, beside a syringe on a yellow caution mat labeled "Chemotherapy Drugs: Observe Safety Precautions for Handling."

Repackaged cancer drug boosts delivery to tumors, improves combination therapies

Aug. 21, 2025

BIO5 member Jianqin Lu and colleagues developed a new paclitaxel formulation, Paclitaxome, that improves drug delivery to tumors while reducing side effects.

Read more in U of A Research and Partnerships
Read all news
BIO5 Institute | Home

Information For

  • Researchers
  • Postdoctoral Researchers
  • Students
  • Industry Partners
  • Community

About

  • Getting Started
  • What is the BIO5 Institute?
  • Become a Member
  • Visit
  • Invest In BIO5
  • BIO5 Art Collection

Resources

  • News
  • Calendar of Events
  • Newsletter
  • Science Talks Podcast
  • BIO5 Resources
  • Submit BIO5 IT & Facilities Ticket

Connect

  • Facebook
  • X, formerly Twitter
  • Instagram
  • LinkedIn
  • Spotify
  • YouTube

We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples. Today, Arizona is home to 22 federally recognized tribes, with Tucson being home to the O’odham and the Yaqui. The university strives to build sustainable relationships with sovereign Native Nations and Indigenous communities through education offerings, partnerships, and community service.


University Information Security and Privacy

© 2025 The Arizona Board of Regents on behalf of The University of Arizona.